Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

1.

BRCA1 and γH2AX as independent prognostic markers in oral squamous cell carcinoma.

Oliveira-Costa JP, Oliveira LR, Zanetti R, Zanetti JS, da Silveira GG, Chavichiolli Buim ME, Zucoloto S, Ribeiro-Silva A, Soares FA.

Oncoscience. 2014 Jun 1;1(5):383-91. eCollection 2014.

PMID:
25594033
[PubMed]
Free PMC Article
2.

Standard of care and promising new agents for triple negative metastatic breast cancer.

Mancini P, Angeloni A, Risi E, Orsi E, Mezi S.

Cancers (Basel). 2014 Oct 24;6(4):2187-223. doi: 10.3390/cancers6042187. Review.

PMID:
25347122
[PubMed]
Free PMC Article
3.

Assessment of changes in the BRCA2 and P53 genes in breast invasive ductal carcinoma in northeast Brazil.

Ramalho EA, Silva-Filho JL, Cartaxo MF, Cavalcanti CB, Rêgo MJ, Oliveira MB, Beltrão EI.

Biol Res. 2014 Mar 26;47(1):3. doi: 10.1186/0717-6287-47-3.

PMID:
25027116
[PubMed - in process]
Free PMC Article
4.

A paradoxical chemoresistance and tumor suppressive role of antioxidant in solid cancer cells: a strange case of Dr. Jekyll and Mr. Hyde.

Kwee JK.

Biomed Res Int. 2014;2014:209845. doi: 10.1155/2014/209845. Epub 2014 Apr 3. Review.

PMID:
24800215
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status.

Cunningham JM, Cicek MS, Larson NB, Davila J, Wang C, Larson MC, Song H, Dicks EM, Harrington P, Wick M, Winterhoff BJ, Hamidi H, Konecny GE, Chien J, Bibikova M, Fan JB, Kalli KR, Lindor NM, Fridley BL, Pharoah PP, Goode EL.

Sci Rep. 2014 Feb 7;4:4026. doi: 10.1038/srep04026.

PMID:
24504028
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

DNA damage response genes and the development of cancer metastasis.

Broustas CG, Lieberman HB.

Radiat Res. 2014 Feb;181(2):111-30. doi: 10.1667/RR13515.1. Epub 2014 Jan 7. Review.

PMID:
24397478
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis.

Saldanha SN, Tollefsbol TO.

J Cell Physiol. 2014 Apr;229(4):393-406. doi: 10.1002/jcp.24466. Review.

PMID:
24105793
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Strategies for optimizing the response of cancer and normal tissues to radiation.

Moding EJ, Kastan MB, Kirsch DG.

Nat Rev Drug Discov. 2013 Jul;12(7):526-42. doi: 10.1038/nrd4003. Review.

PMID:
23812271
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.

Tang S, Bonaroti J, Unlu S, Liang X, Tang D, Zeh HJ, Lotze MT.

Pancreas. 2013 Jul;42(5):740-59. doi: 10.1097/MPA.0b013e3182854ab0. Review.

PMID:
23774697
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer.

da Silva HB, Amaral EP, Nolasco EL, de Victo NC, Atique R, Jank CC, Anschau V, Zerbini LF, Correa RG.

Prostate Cancer. 2013;2013:920612. doi: 10.1155/2013/920612. Epub 2013 Apr 29.

PMID:
23738079
[PubMed]
Free PMC Article
11.

PGD for hereditary breast and ovarian cancer: the route to universal tests for BRCA1 and BRCA2 mutation carriers.

Drüsedau M, Dreesen JC, Derks-Smeets I, Coonen E, van Golde R, van Echten-Arends J, Kastrop PM, Blok MJ, Gómez-García E, Geraedts JP, Smeets HJ, de Die-Smulders CE, Paulussen AD.

Eur J Hum Genet. 2013 Dec;21(12):1361-8. doi: 10.1038/ejhg.2013.50. Epub 2013 Mar 27.

PMID:
23531862
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.

Lesnock JL, Darcy KM, Tian C, Deloia JA, Thrall MM, Zahn C, Armstrong DK, Birrer MJ, Krivak TC.

Br J Cancer. 2013 Apr 2;108(6):1231-7. doi: 10.1038/bjc.2013.70. Epub 2013 Mar 5.

PMID:
23462720
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Molecular pathways: targeting PARP in cancer treatment.

Do K, Chen AP.

Clin Cancer Res. 2013 Mar 1;19(5):977-84. doi: 10.1158/1078-0432.CCR-12-0163. Epub 2012 Dec 26.

PMID:
23269547
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib.

Daemen A, Wolf DM, Korkola JE, Griffith OL, Frankum JR, Brough R, Jakkula LR, Wang NJ, Natrajan R, Reis-Filho JS, Lord CJ, Ashworth A, Spellman PT, Gray JW, van't Veer LJ.

Breast Cancer Res Treat. 2012 Sep;135(2):505-17. doi: 10.1007/s10549-012-2188-0. Epub 2012 Aug 9.

PMID:
22875744
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A new hypothesis for the cancer mechanism.

Meng X, Zhong J, Liu S, Murray M, Gonzalez-Angulo AM.

Cancer Metastasis Rev. 2012 Jun;31(1-2):247-68. doi: 10.1007/s10555-011-9342-8. Review.

PMID:
22179983
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.

Yang D, Khan S, Sun Y, Hess K, Shmulevich I, Sood AK, Zhang W.

JAMA. 2011 Oct 12;306(14):1557-65. doi: 10.1001/jama.2011.1456. Erratum in: JAMA. 2012 Jan 25;307(4):363.

PMID:
21990299
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.

Zhu Q, Pao GM, Huynh AM, Suh H, Tonnu N, Nederlof PM, Gage FH, Verma IM.

Nature. 2011 Sep 7;477(7363):179-84. doi: 10.1038/nature10371.

PMID:
21901007
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Poly(ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer?

Plummer R.

Breast Cancer Res. 2011 Aug 16;13(4):218. doi: 10.1186/bcr2877. Review.

PMID:
21884642
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Evaluating the effects of genetic variants of DNA repair genes using cytogenetic mutagen sensitivity approaches.

Abdel-Rahman SZ, El-Zein RA.

Biomarkers. 2011 Aug;16(5):393-404. doi: 10.3109/1354750X.2011.577237. Epub 2011 May 20. Review.

PMID:
21595606
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Characteristics of triple-negative breast cancer.

de Ruijter TC, Veeck J, de Hoon JP, van Engeland M, Tjan-Heijnen VC.

J Cancer Res Clin Oncol. 2011 Feb;137(2):183-92. doi: 10.1007/s00432-010-0957-x. Epub 2010 Nov 11. Review.

PMID:
21069385
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk